Myeloma and lymphoma: exercise before cellular therapy shows preliminary results

Building fitness before treatment could help adults with multiple myeloma or lymphoma preserve certain functional abilities. A systematic review involving 501 participants reports generally favorable results for physical function and lower-limb performance. But most studies do not allow these results to be confidently attributed to exercise.

Illustration of physical preparation before cellular therapy in adults with myeloma or lymphoma.
TrainingEditorial illustration, not study data.

Training started before treatment

Fatigue, physical deconditioning and muscle weakness can compromise readiness for treatment and quality of life. The prehabilitation studied here involves starting exercise before therapy, rather than waiting until recovery.

The researchers searched six databases for randomized trials and quasi-experimental studies in adults with multiple myeloma or lymphoma. Programs had to begin before stem cell transplantation, CAR-T therapy or treatment with a bispecific T-cell engager antibody, known as BiTE.

The review includes twelve studies: three pilot randomized trials and nine quasi-experimental studies. Ten concerned transplantation and two concerned CAR-T therapy. None examined BiTE treatments, so the conclusions cannot be extended to that approach.

More consistent results for physical function

Most programs combined aerobic exercise and strength training. Nine reported a central or protocol-planned duration of four to eight weeks. How often this duration appeared in the studies does not establish it as optimal.

Results were generally favorable for physical function and lower-limb performance. However, findings for grip strength, quality of life and fatigue were mixed. A favorable functional signal therefore does not mean a consistent improvement in patients’ lived experience.

The results were synthesized narratively. The available abstract provides no pooled numerical estimate of benefit: this dossier therefore cannot establish the size of any expected improvement.

An approach to confirm, not a validated program

Heterogeneous methods and the predominance of studies without a control group limit interpretation. The three randomized trials were pilot trials, and the authors call for adequately powered trials specific to each therapy.

Safety and sustained recovery after treatment also remain to be assessed. This review supports further research into physical preparation, but it cannot establish a standard program or demonstrate better treatment tolerance.

Limitations to keep in mind

Only the PubMed abstract was consulted, not the full text. The studies are heterogeneous and mostly uncontrolled. None concerns BiTE treatments. The clinical magnitude of the benefits, safety and whether benefits persist after treatment cannot be established from this excerpt. Funding and conflicts of interest were not checked.

What we can take away

Exercise started before transplantation or CAR-T therapy could help improve functional readiness. The evidence of benefit remains preliminary, with no consistent improvement demonstrated in fatigue or quality of life.

Sources and provenance

Partager cet article

X f in

An error or a source to report? Contact the editorial team.